ResMed | RMD - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Ansell USD 880.1M 465.65M 2025-12
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 140.72M 2.71M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Cochlear AUD 914.9M 454.8M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
CSL USD 5.7B 2.82B 2025-12
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Fisher Paykel Healthcare NZD 802.4M 24.1M 2025-12
Globus Medical USD 595.85M 49.26M 2026-03
Haemonetics USD 134.99M 1.26M 2025-12
Idexx Laboratories USD 778.23M 3.26M 2026-03
Inogen USD 49.14M 665K 2024-09
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
Masimo USD 326.2M 2.4M 2026-03
Medtronic USD 7.28B 16M 2025-12
Philips EUR 3.6B 775M 2026-03
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 925.74M 525K 2026-03
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Steris USD 1.27B 51.5M 2026-03
Teleflex USD 3.08B 2.55B 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03